Income Statement (TTM)
Serina Therapeutics, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 1 | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
| Change (%) | -82.93 | -37.19 | -65.41 | -3.81 | 2,451.31 | -0.81 | 1.41 | -0.46 | -98.23 | -8.93 | 154.90 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 6 | 7 | 9 | 11 |
| Change (%) | -59.28 | -2.80 | 4.18 | 10.28 | 38.23 | 29.61 | 36.03 | 43.02 | 24.23 | 24.67 | 16.71 | |
| % of Revenue | 109.64 | 261.53 | 404.75 | 1,219.06 | 1,397.66 | 75.73 | 98.95 | 132.72 | 190.70 | 13,357.14 | 18,284.31 | 8,371.54 |
| Gross Operating Profit | -0 | -1 | -1 | -1 | -2 | 1 | 0 | -1 | -3 | -7 | -9 | -11 |
| Change (%) | 186.19 | 18.49 | 27.02 | 11.54 | -149.73 | -95.86 | -3,245.45 | 175.89 | 159.24 | 24.92 | 15.95 | |
| % of Revenue | -9.64 | -161.53 | -304.75 | -1,119.06 | -1,297.66 | 25.29 | 1.05 | -32.72 | -90.70 | -13,257.14 | -18,184.31 | -8,271.54 |
| SG&A | 1 | 1 | 2 | 2 | 2 | 4 | 3 | 5 | 8 | 8 | 10 | 10 |
| Change (%) | 1.33 | 24.78 | 10.95 | 35.28 | 59.40 | -25.56 | 63.31 | 75.88 | -2.92 | 20.70 | 2.24 | |
| % of Revenue | 37.45 | 222.31 | 441.65 | 1,416.61 | 1,992.30 | 124.47 | 93.41 | 150.44 | 265.81 | 14,550.00 | 19,284.31 | 7,734.62 |
| R&D | ||||||||||||
| Change (%) | ||||||||||||
| % of Revenue | ||||||||||||
| OpEx | 5 | 3 | 3 | 3 | 4 | 6 | 6 | 9 | 14 | 16 | 19 | 21 |
| Change (%) | -43.84 | 9.87 | 7.71 | 23.72 | 49.91 | -4.21 | 49.28 | 60.48 | 8.42 | 22.60 | 9.28 | |
| % of Revenue | 147.09 | 483.83 | 846.39 | 2,635.68 | 3,389.96 | 199.18 | 192.36 | 283.17 | 456.51 | 27,907.14 | 37,568.63 | 16,106.15 |
| Operating Income | -2 | -2 | -3 | -3 | -4 | -2 | -3 | -6 | -11 | -16 | -19 | -21 |
| Change (%) | 39.16 | 22.13 | 17.51 | 24.80 | -62.38 | 88.82 | 101.11 | 93.75 | 38.34 | 22.71 | 8.89 | |
| % of Revenue | -47.09 | -383.83 | -746.39 | -2,535.68 | -3,289.96 | -48.52 | -92.36 | -183.17 | -356.51 | -27,807.14 | -37,468.63 | -16,006.15 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -0 | -0 |
| Change (%) | 413.19 | 541.63 | 106.04 | 89.56 | 40.23 | 17.92 | 30.24 | -20.06 | -23.22 | -35.36 | -87.65 | |
| % of Revenue | -0.09 | -2.68 | -27.42 | -163.36 | -321.93 | -17.69 | -21.04 | -27.02 | -21.70 | -939.29 | -666.67 | -32.31 |
| Net Income | -1 | -3 | -0 | 1 | 4 | 5 | -11 | -7 | -7 | -11 | -1 | -13 |
| Change (%) | 112.07 | -88.09 | -473.74 | 203.29 | 45.59 | -316.40 | -38.55 | 4.87 | 51.60 | -91.57 | 1,240.89 | |
| % of Revenue | -36.50 | -453.44 | -85.96 | 928.76 | 2,928.39 | 167.11 | -364.58 | -220.93 | -232.75 | -19,894.64 | -1,841.18 | -9,685.38 |
Source: Capital IQ
